A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection

Transfusion

Volumn 37, Issue 8, 1997, Pages 850-857

  Almeida, I C ^a   Covas, D T ^b   Soussumi, L M T ^c   Travassos, L R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fundacao Hemocentro de Ribeirao Preto   (Brazil)

^c NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN DETECTION; ARTICLE; BLOOD BANK; CHAGAS DISEASE; CHEMOLUMINESCENCE; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; SCREENING; SERODIAGNOSIS; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

EID: 0030812978     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37897424410.x     Document Type: Article

References (38)

1. Hayes RJ, Schofield CJ. [Estimating incidence rates of chronic infections from prevalence data: Chagas' disease in Latin America] (Engl abstract). Bol Of Sanit Panam 1990;108:308-16.
2. Shulman IA. Parasitic infections, an uncommon risk of blood transfusion in the United States (editorial). Transfusion 1991;31:479-80.
3. Geiseler PJ, Ito JI, Tegtemeier BR, et al. Fulminant Chagas' disease in bone marrow transplantation (abstract). Washington: American Society of Microbiology 1987:418.
4. Grant IH, Gold JW, Wittner M, et al. Transfusion-associated acute Chagas disease acquired in the United States. Ann Intern Med 1989;111:849-51.
5. Nickerson P, Orr P, Schroeder ML, et al. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med 1989;111:851-3.
6. Villalba R, Fornés G, Alvarez MA, et al. Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report. Clin Infect Dis 1992;14:594-5.
7. Wendel Neto S. Current concepts on the transmission of bacteria and parasites by blood components. São Paulo Med J 1995;113:1036-52.
8. Kerndt PR, Waskin HA, Kirchhoff LV. Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California. Transfusion 1991;31:814-8.
9. Pan AA, Brashear J, Schur JD, et al. Prevalence study and confirmation of seropositive antibodies to Trypanosoma cruzi (Chagas' disease) in Hispanic and non-Hispanic blood donors in the United States (abstract). Rev Paul Med 1992;110:TTD18.
10. Brashear RJ, Winkler MA, Schur JD, et al. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I. Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T. cruzi. Transfusion 1995;35:213-8.
11. Galel SA, Kirchhoff LV. Risk factors for Trypanosoma cruzi infection in California blood donors. Transfusion 1996;36:227-31.
12. Paranhos-Bacalla GS, Santos MR, Cotrim PC, et al. Detection of antibodies in sera from Chagas' disease patients using a Trypanosoma cruzi immunodominant recombinant antigen. Parasite Immunol 1994;16:165-9.
13. Krautz GM, Galvão LM, Cançado JR, et al. Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease. J Clin Microbiol 1995;33:2086-90.
14. Vergara U, Lorca M, Veloso C, et al. Assay for detection of Trypanosoma cruzi antibodies in human sera based on reaction with synthetic peptides. J Clin Microbiol 1991;29:2034-7.
15. Moncayo A, Luquetti AO. Multicentre double blind study for evaluation of Trypanosoma cruzi defined antigens as diagnostic reagents. Mem Inst Oswaldo Cruz 1990;85:489-95.
16. Godsel LM, Tibbetts RS, Olson CL, et al. Utility of recombinant flagellar calcium-binding protein for serodiagnosis of Trypanosoma cruzi infection. J Clin Microbiol 1995;33:2082-5.
17. Peralta JM, Teixeira MG, Shreffler WG, et al. Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens. J Clin Microbiol 1994;32:971-4.
18. Zingales B, Golgher DB, Marmorato PG, et al. Molecular approaches to diagnosis of Chagas' disease: use of defined antigens and a target ribosomal RNA sequence. Biol Res 1993;26:89-100.
19. Almeida E, Krieger MA, Carvalho MR, et al. Use of recombinant antigens for the diagnosis of Chagas disease and blood bank screening. Mem Inst Oswaldo Cruz 1990;85:513-7.
20. Krieger MA, Almeida E, Oelemann W, et al. Use of recombinant antigens for the accurate immunodiagnosis of Chagas' disease. Am J Trop Med Hyg 1992;46:427-34.
21. Carvalho MR, Krieger MA, Almeida E, et al. Chagas' disease diagnosis: evaluation of several tests in blood bank screening. Transfusion 1993;33:830-4.
22. Wincker P, Britto C, Pereira JB, et al. Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. Am J Trop Med Hyg 1994;51:771-7.
23. Avila HA, Pereira JB, Thiemann O, et al. Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis. J Clin Microbiol 1993;31:2421-6.
24. Andrews NW, Colli W. Adhesion and interiorization of Trypanosoma cruzi in mammalian cells. J Protozool 1982;29:264-9.
25. Almeida IC, Ferguson MA, Schenkman S, Travassos LR. Lytic anti-α-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem J 1994;304:793-802.
26. Schnaidman BB, Yoshida N, Gorin PA, Travassos LR. Cross-reactive polysaccharides from Trypanosoma cruzi and fungi (especially Dactylium dendroides). J Protozool 1986;33:186-91.
27. Krouwer JS, Rabinowitz R. How to improve estimates of imprecision. Clin Chem 1984;30:290-2.
28. Travassos LR, Almeida IC, Milani SR, Gorin PA. Antibody specificity in the conventional serology for Chagas' disease. Ci Cult J Braz Assoc Adv Sci 1993;45:69-73.
29. Almeida IC, Krautz GM, Krettli AU, Travassos LR. Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-α-galactosyl antibodies from patients with chronic Chagas disease. J Clin Lab Anal 1993;7:307-16.
30. Galvão LM, Nunes RM, Cançado JR, et al. Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 year follow-up study. Trans R Soc Trop Med Hyg 1993;87:220-3.
31. Krettli AU, Cançado JR, Brener Z. Criterion of cure of human Chagas' disease after specific chemotherapy: recent advances. Mem Inst Oswaldo Cruz 1984;79:157-64.
32. Almeida IC, Milani SR, Gorin PA, Travassos LR. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-α-galactosyl antibodies. J Immunol 1991;146:2394-400.
33. Previato JO, Jones C, Gonçalves LP, et al. O-glycosidically linked N-acetylglucosamine-bound oligosaccharides from glycoproteins of Trypanosoma cruzi. Biochem J 1994;301:151-9.
34. Serrano AA, Schenkman S, Yoshida N, et al. The lipid structure of the glycosylphosphatidylinositol-anchored mucin-like sialic acid acceptors of Trypanosoma cruzi changes during parasite differentiation from epimastigotes to infective metacyclic trypomastigote forms. J Biol Chem 1995;270:27244-53.
35. De Andrade AL, Zicker F, Oliveira RM, et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996;348:1407-13.
36. Mac Kenzie WR, Davis JP, Peterson DE, et al. Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991. JAMA 1992;268:1015-7.
37. Tannock GA, Bryce DA, Barnett GR, et al. Measurement of IgM responses to a subunit influenza A vaccine by sucrose-gradient centrifugation and membrane-filtration enzyme immunoassays. Biologicals 1991;19:17-21.
38. Oliveira TG, Milani SR, Travassos LR. Polyclonal B-cell activation byNeisseria meningitidis capsular polysaccharides elicit antibodies protective against Trypanosoma cruzi infection in vitro. J Clin Lab Anal 1996;10:220-8.